|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
Q3 FY2020
As of Sep 30, 2020
|
Q2 FY2020
As of Jun 30, 2020
|
Q1 FY2020
As of Mar 31, 2020
|
Q4 FY2019
As of Dec 31, 2019
|
Q3 FY2019
As of Sep 30, 2019
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Loans held for sale, at fair value | ||||||||||||||||||||
| Loans held for investment, at fair value | ||||||||||||||||||||
| Accrued interest on loans held for investment | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Front Yard common stock, at fair value | ||||||||||||||||||||
| Common Stock | ||||||||||||||||||||
| Total front Yard common stock, at fair value | ||||||||||||||||||||
| Receivable from Front Yard | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Current assets held for sale | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Loans held for investment, at fair value | ||||||||||||||||||||
| Right-of-use lease assets | ||||||||||||||||||||
| Other non-current assets | ||||||||||||||||||||
| Non-current assets held for sale | ||||||||||||||||||||
| Total non-current assets | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Accrued salaries and employee benefits | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Short-term lease liabilities | ||||||||||||||||||||
| Current liabilities held for sale | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Long-term lease liabilities | ||||||||||||||||||||
| Other non-current liabilities | ||||||||||||||||||||
| Non-current liabilities held for sale | ||||||||||||||||||||
| Total non-current liabilities | ||||||||||||||||||||
| Accrued expenses and other liabilities | ||||||||||||||||||||
| Lease liabilities | ||||||||||||||||||||
| Credit facility | ||||||||||||||||||||
| Notes payable, including accrued paid-in-kind interest | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Commitment and contingencies (Note 4) | ||||||||||||||||||||
| Redeemable preferred stock: | ||||||||||||||||||||
| Preferred stock, $0.01 par value, 250,000 shares authorized as of June 30, 2024 and December 31, 2023. No shares were issued and outstanding as of June 30, 2024. 144,212 shares were issued and outstanding and had a $144,212 redemption value as of December 31, 2023. | ||||||||||||||||||||
| Stockholders' equity (deficit) | ||||||||||||||||||||
| Common stock, $0.01 par value, 5,000,000 authorized shares; 4,684,485 and 2,554,512 shares issued and outstanding, respectively, as of June 30, 2024 and December 31, 2023. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive income | ||||||||||||||||||||
| Treasury stock, at cost, 1,360,980 shares as of March 31, 2022 and December 31, 2021. | ||||||||||||||||||||
| Treasury stock, at cost, 2,129,973 shares as of June 30, 2024 and December 31, 2023. | ||||||||||||||||||||
| Total stockholders' equity (deficit) | ||||||||||||||||||||
| Total liabilities, redeemable preferred stock and stock holders' equity | ||||||||||||||||||||
Loading...
